FDA Memo on Vaccine Deaths Sends Moderna, Novavax Stocks Tumbling

Moderna and Novavax shares drop 5-6% after FDA's vaccine chief links COVID-19 shots to 10 children's deaths and announces stricter vaccine approval standards.